AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2019

Nov 21, 2019

31071_dirs_2019-11-20_7ded1b67-4968-40d4-b6e0-fda76f96b9f2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2019-11-18

Reporting Person: Bradshaw Curt (Chief Scientific Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	125000	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments beginning on November 18, 2020.